| Cash |
802K |
| Prepaid expenses and other current assets |
785K |
| Total current assets |
2.27M |
| Laboratory equipment |
| Office furniture and other equipment |
| Property, Plant and Equipment, Gross, Total |
| Less accumulated depreciation and amortization |
| Property and equipment, net |
46.55M |
| Deposit and other non-current assets |
| Total assets |
48.94M |
| Accounts payable |
13.34M |
| Accounts payable, related party |
11.85M |
| Accrued expenses |
1.3M |
| Accrued expenses, related party |
| Notes payable |
| Note payable to related parties |
| Convertible notes payable, net |
10.94M |
| Convertible notes payable to related party, net |
| Embedded derivative liability |
| Liability for reclassified equity contracts |
| Total current liabilities |
53.96M |
| Notes payable, net |
| Convertible notes payable, net |
0 |
| Convertible notes payable to related party, net |
| Total long term liabilities |
0 |
| Total liabilities |
53.96M |
| Preferred stock, $0.001 par value; 20,000,000 shares authorized and none issued and outstanding |
0 |
| Common stock, $0.001 par value; 150,000,000 shares authorized, 73,118,471 and 93,418,586 shares issued and outstanding at December 31, 2010 and June 30, 2011, respectively |
121K |
| Additional paid-in capital |
678.62M |
| Deficit accumulated during the development stage |
| Cumulative translation adjustment |
| Total stockholders' equity (deficit) |
-5.02M |
| Total liabilities and stockholders' equity (deficit) |
48.94M |
